Valuation: DexCom, Inc.

Market Cap 3.21TCr 2.87TCr 2.67TCr 2.42TCr 4.56TCr 3,04700Cr 4.6TCr 32TCr 13TCr 1,58500Cr 12TCr 12TCr 5,08500Cr P/E 2026 *
34.2x
P/E 2027 * 28.8x
Enterprise Value 3.13TCr 2.8TCr 2.61TCr 2.37TCr 4.45TCr 2,97500Cr 4.49TCr 31TCr 12TCr 1,54700Cr 12TCr 12TCr 4,96400Cr EV / Sales 2026 *
5.99x
EV / Sales 2027 * 5.36x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-1.00%
1 week+2.00%
Current month-1.43%
1 month+2.44%
3 months+11.41%
6 months+34.76%
Current year+28.16%
1 week 82.94
Extreme 82.935
86.6
1 month 82.86
Extreme 82.86
90.38
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Sell

Head of Human Resources

-2,565 0.0007%
15/09/26 Sell

Compliance Officer

-1,700 0.0005%
15/09/26 Sell

Director

-6,539 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%+2.00%+30.46%+11.64% 3.21TCr
+0.78%+4.53%-21.90%+12.92% 18TCr
+1.17%+6.80%-2.69%+29.25% 12TCr
-0.02%+1.56%-22.57%+9.57% 11TCr
-0.31%-0.27%-46.72%-10.85% 7.53TCr
+1.55%+4.34%+4.14%+74.68% 6.3TCr
+1.26%+1.99%+20.86%+68.54% 5.35TCr
-0.80%+3.92%+0.38%-27.57% 5.1TCr
-0.69%+0.95%-17.84%+22.09% 4.1TCr
-0.17%+0.42% - - 3.13TCr
Average +0.18%+2.68%-6.21%+21.14% 7.52TCr
Weighted average by Cap. +0.41%+3.29%-11.83%+19.75%

Financials

2026 *2027 *
Net sales 522.93Cr 467.13Cr 435.4Cr 394.75Cr 742.89Cr 50TCr 748.73Cr 5.22TCr 2.04TCr 26TCr 1.96TCr 1.92TCr 83TCr 579.32Cr 517.51Cr 482.36Cr 437.32Cr 823Cr 55TCr 829.47Cr 5.78TCr 2.26TCr 29TCr 2.18TCr 2.13TCr 92TCr
Net income 97Cr 87Cr 81Cr 73Cr 138.24Cr 9.24TCr 139.32Cr 970.57Cr 379.95Cr 4.8TCr 365.44Cr 357.42Cr 15TCr 114.57Cr 102.35Cr 95Cr 86Cr 162.77Cr 11TCr 164.05Cr 1.14TCr 447.38Cr 5.66TCr 430.3Cr 420.86Cr 18TCr
Net Debt -76Cr -68Cr -63Cr -57Cr -108.13Cr -7.22TCr -108.98Cr -759.2Cr -297.2Cr -3.76TCr -285.85Cr -279.58Cr -12TCr -106.15Cr -95Cr -88Cr -80Cr -150.8Cr -10TCr -151.98Cr -1.06TCr -414.47Cr -5.24TCr -398.65Cr -389.9Cr -17TCr
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
13/26/13 $85.06 -1.00% 40,17,079
12/26/12 $85.92 +2.15% 29,92,133
09/26/09 $84.11 -0.36% 31,54,204
08/26/08 $84.41 +0.13% 36,07,110
07/26/07 $84.30 +1.09% 28,63,835
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
85.06USD
Average target price
96.46USD
Spread / Average Target
+13.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.
  1. Stock Market
  2. Stocks
  3. DXCM Stock